Cargando…
Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics
The design and development of analgesics with mixed-opioid receptor interactions has been reported to decrease side effects, minimizing respiratory depression and reinforcing properties to generate safer analgesic therapeutics. We synthesized bis-cyclic guanidine heterocyclic peptidomimetics from re...
Autores principales: | McLaughlin, Jay P., Rayala, Ramanjaneyulu, Bunnell, Ashley J., Tantak, Mukund P., Eans, Shainnel O., Nefzi, Khadija, Ganno, Michelle L., Dooley, Colette T., Nefzi, Adel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455983/ https://www.ncbi.nlm.nih.gov/pubmed/36077029 http://dx.doi.org/10.3390/ijms23179623 |
Ejemplares similares
-
Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration
por: Rayala, Ramanjaneyulu, et al.
Publicado: (2023) -
Direct Phenotypic Screening in Mice: Identification
of Individual, Novel Antinociceptive Compounds from a Library of 734 821
Pyrrolidine Bis-piperazines
por: Houghten, Richard A., et al.
Publicado: (2015) -
Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles
por: Brice-Tutt, Ariana C., et al.
Publicado: (2020) -
Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide
por: Li, Yangmei, et al.
Publicado: (2023) -
Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice
por: Spetea, Mariana, et al.
Publicado: (2017)